INFINITY PHARMACEUTICALS INC's ticker is and the CUSIP is 45665G953. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 600 | -94.4% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 10,700 | +0.9% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 10,600 | +14.0% | 0.00% | – |
| Q2 2022 | $5,000 | -54.5% | 9,300 | -7.0% | 0.00% | – |
| Q1 2022 | $11,000 | -86.7% | 10,000 | -73.0% | 0.00% | – |
| Q4 2021 | $83,000 | -64.4% | 37,000 | -52.5% | 0.00% | – |
| Q3 2021 | $233,000 | +0.9% | 77,900 | +0.6% | 0.00% | – |
| Q2 2021 | $231,000 | -40.2% | 77,400 | +6371.6% | 0.00% | -100.0% |
| Q1 2021 | $386,000 | +512.7% | 1,196 | +301.3% | 0.00% | – |
| Q4 2020 | $63,000 | +2000.0% | 298 | +861.3% | 0.00% | – |
| Q3 2020 | $3,000 | -57.1% | 31 | -22.5% | 0.00% | – |
| Q2 2018 | $7,000 | +250.0% | 40 | -11.1% | 0.00% | – |
| Q1 2018 | $2,000 | – | 45 | +104.5% | 0.00% | – |
| Q4 2017 | $0 | – | 22 | +2100.0% | 0.00% | – |
| Q2 2017 | $0 | – | 1 | -90.9% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 11 | -98.4% | 0.00% | -100.0% |
| Q4 2016 | $17,000 | +466.7% | 676 | +1252.0% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 50 | -43.8% | 0.00% | – |
| Q2 2016 | $4,000 | – | 89 | +2125.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 4 | -63.6% | 0.00% | – |
| Q3 2015 | $2,000 | +100.0% | 11 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -96.9% | 11 | -96.3% | 0.00% | -100.0% |
| Q1 2015 | $32,000 | +966.7% | 294 | +740.0% | 0.00% | – |
| Q4 2014 | $3,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 7,600 | $16,000 | 0.00% |
| SIMPLEX TRADING, LLC | 298 | $63,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |